What are acylcarnitines?
Acylcarnitines are chemical intermediates in fatty acid oxidation, the metabolic process your body uses to convert fat into energy (ATP). When your cells need fuel — during fasting, intense exercise, or ketogenic diet — they break down fatty acids in the mitochondria through a multi-step process called beta-oxidation. At each step, the fatty acid chain is bound to carnitine, creating an acylcarnitine molecule.
Think of acylcarnitines as snapshots of the energy production assembly line. Each acylcarnitine species (C2, C4, C6, C8, C10, C12, C14, C16, C18) represents a different stage in fat burning. If a particular acylcarnitine is elevated or depleted, it tells clinicians exactly which metabolic step is struggling.
Short, medium, long, and very-long-chain species
Short-chain acylcarnitines (C0-C4): These reflect the early and final steps of fatty acid oxidation, including the entry of fat into the mitochondria. Free carnitine (C0) shuttles fatty acids across the mitochondrial membrane. Acetylcarnitine (C2) is the endpoint of beta-oxidation and can indicate overall metabolic rate and cellular energy status.
Medium-chain species (C6-C10): These represent the active oxidation of medium-chain fatty acids, typically derived from dietary fat and short-chain fat sources. Medium-chain acylcarnitines are particularly useful for detecting inherited disorders of medium-chain acyl-CoA dehydrogenase (MCAD), one of the most common fatty acid oxidation disorders.
Long-chain species (C12-C18): These reflect the oxidation of long-chain dietary fats and omega-3 and omega-6 polyunsaturated fatty acids. Elevated long-chain acylcarnitines can indicate carnitine palmitoyltransferase (CPT) deficiency or other disorders affecting long-chain fat transport into the mitochondria.
Very-long-chain species (C20-C22): These measure the oxidation of very-long-chain fatty acids and are particularly relevant in peroxisomal disorders like X-linked adrenoleukodystrophy (ALD) and other rare metabolic conditions.
Newborn screening and rare disease diagnosis
Acylcarnitine profiling is the gold standard for newborn screening of inborn errors of fatty acid oxidation and organic acid metabolism. A single dried blood spot reveals disorders like MCAD deficiency, long-chain 3-hydroxyacyl-CoA dehydrogenase (LCHAD) deficiency, carnitine transporter deficiency, and others that can cause sudden death or severe neurological injury if missed at birth.
In older children and adults, acylcarnitine profiles help diagnose unexplained muscle weakness, developmental delay, seizures, cardiomyopathy, or recurrent unexplained hypoglycemia. For clinicians in rare disease genetics and metabolic medicine, acylcarnitine profiling is an essential diagnostic tool.
Beyond rare disease: Mitochondrial health and metabolic flexibility
More recently, acylcarnitine profiling has expanded beyond rare disease into clinical assessment of metabolic health. Researchers have observed that individuals with mitochondrial dysfunction, chronic fatigue syndrome, or impaired metabolic flexibility often show altered acylcarnitine patterns even without classic genetic disorders.
Athletes and performance-focused individuals are increasingly using acylcarnitine panels to assess their capacity for fat oxidation and metabolic flexibility — the ability to switch between carbohydrate and fat fuel. Studies suggest that training status and metabolic adaptation to low-carbohydrate diets produce detectable changes in the acylcarnitine profile, making it a potential biomarker for training response and nutritional intervention efficacy.
Why a 23-analyte panel matters
Free carnitine alone is insufficient. A person with severely impaired fatty acid oxidation might have normal free carnitine levels if their body is trying to compensate by not using carnitine. It's like checking only the fuel tank gauge without looking at the engine; you can't tell if the fuel is actually being burned.
A comprehensive 23-analyte panel spanning C0 through C18:1 provides a complete metabolic fingerprint. It reveals which specific steps of fatty acid oxidation are working and which are failing. For newborn screening, this specificity enables targeted diagnostic follow-up and early intervention. For metabolic assessment in athletes and functional medicine, it quantifies metabolic capacity and reveals the impact of diet and training on mitochondrial function.
Testing via dried blood spot and LC-MS/MS
At Masdiag, acylcarnitine profiling is performed from a dried blood spot sample using liquid chromatography-tandem mass spectrometry (LC-MS/MS). This method is highly specific, separating each acylcarnitine species by mass and detecting them with precision. A single finger-prick collection card is sufficient; no special handling or refrigeration is required during transit.
The same dried blood spot sample can simultaneously measure amino acids, organic acids, and other metabolites, making DBS an efficient approach to comprehensive metabolic screening. Results are typically available within 5-7 days, and dried blood spot sampling enables newborn screening programs and at-home testing for patients and practitioners worldwide.
Frequently asked questions
What are acylcarnitines and why do they matter?
Acylcarnitines are biochemical intermediates in fatty acid oxidation, the primary pathway your body uses to convert fat into energy. When you fast, exercise, or rely on fat for fuel, your cells generate carnitine-bound fatty acid molecules at each step of beta-oxidation. Each chain length (short, medium, long) reflects different metabolic steps and energy processes. Abnormal acylcarnitine profiles indicate metabolic dysfunction, genetic enzyme deficiencies, or impaired mitochondrial function.
Why measure 23 acylcarnitines instead of just free carnitine?
Free carnitine alone is a poor marker of metabolic health. It doesn't tell you which metabolic steps are working or failing. A comprehensive 23-analyte panel including short-chain (C0-C4), medium-chain (C6-C10), long-chain (C12-C18), and very-long-chain species (C20-C22) reveals the complete picture of fatty acid oxidation capacity, mitochondrial function, and specific enzyme activity. This specificity enables diagnosis of rare genetic disorders and detection of metabolic impairment that a single biomarker would miss.
Can acylcarnitine profiling be useful outside of rare disease diagnosis?
Yes. Acylcarnitine profiles are increasingly used to assess metabolic flexibility, mitochondrial fitness, and energy production capacity in athletes and performance-focused individuals. Studies have shown correlations between acylcarnitine patterns and exercise capacity, recovery rate, and metabolic efficiency in ketogenic and low-carbohydrate diets. Integrative practitioners also use acylcarnitine patterns to guide interventions for chronic fatigue, metabolic syndrome, and mitochondrial dysfunction.
Learn About Our Acylcarnitine Panel
Comprehensive 23-analyte acylcarnitine profiling from a single dried blood spot sample via LC-MS/MS. Ideal for newborn screening, rare disease diagnosis, and metabolic assessment.
View Amino Acids & Acylcarnitines →